Revival Operating Partner Todd M. Pope

Todd M. pope

Partner

Todd M. Pope brings 30 years of technology, medical device, and leadership experience across large cap and start-up medtech. His last 20 years have been in CEO roles of both private and public companies.

Todd serves as the Chairman of the Board of Directors of AdvaMed ACCEL. Todd was most recently the President and CEO, of WellAir, a healthy indoor air solutions provider which recently acquired UV Innovators, where Todd served as executive chairman. Prior to joining WellAir, Todd was a Revival Resident Operating Partner.

Before UV Innovators, Todd was the President and CEO of TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options in today's value-based healthcare environment.

Todd’s previous roles included Global President of Johnson & Johnson Cordis; where he led a multi-billion-dollar business unit comprised of 3 distinct companies; Cardiology, Neurovascular, and Peripheral Vascular. Todd has also held various executive positions, including Liquidia Technologies' CEO, a nanotechnology-based healthcare company, in Research Triangle Park, North Carolina. 

He served 14 years in various management roles at Johnson & Johnson's Ethicon Endo-Surgery Division and Boston Scientific, where he rose to Vice President, Global Sales, and Marketing, Neurovascular Division. 

In addition to serving as Chairman of the Board of Directors of AdvaMed ACCEL, Todd is also on the board of directors of Distalmotion, a Revival portfolio company; Humacyte, a regenerative medicine company leveraging a scalable technology platform to develop bioengineered human tissues. Additionally, Todd serves as Chairman of the Board of Avania, a company that advances the research of medical devices, novel technology and a combination of products across a range of therapeutic specialties. He was named to TIME Magazine’s 2018 list of 50 Most Influential People in Health Care.



In the News…